No Detail Found!

Serum Concentration of Cu, Zn and Se in Malignant and Benign Prostatic Lesions.

Author(s)
Raid Jasim M AlTimimi Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University, Baghdad, Iraq
Abstract
Prostate cancer (PCa) is the second leading cause of death among cancer in men. Trace elements are involved in many vital functions. Fluctuations in serum levels of these elements may reflect the occurrence and/or severity of PCa.This prospective case/control study aimed to assess the serum concentration of Cu, Zn and Se in patients with PCa (newly diagnosed and longstanding) and with benign prostatic hyperplasia (BPH). The study recruited 60 patients with PCa (30 newly diagnosed and 30 longstanding patients) and 30 patients with BPH. Other 30 healthy men were randomly selected to be a control group. Sera were separated from blood samples which were collected from each participant. Atomic absorption spectrophotometry was used to measure serum concentration of the studied trace elements. The newly diagnosed patients with PCa showed significantly (P<0.05) higher serum concentration of Cu (3.14±1.1 µg/ml) than each of longstanding group (1.48±0.91 µg/ml), BPH (0.96± 0.17µg/ml), and controls (1.1±0.23 µg/ml), while there were no significant differences between different groups regarding Zn concentration. In newly diagnosed patients, Se concentration was 58.2± 6.12 ng/ml) which is significantly lower than other groups (P<0.05). In longstanding patients, the concentration was relatively high (98.4± 12.38 ng/ml) and differed significantly from patients with BPH (72.4± 8.11 ng/ml) and non-significantly from controls (108.1±15.34 ng/ml) These results indicate that serum levels of Cu and Se undergo a marked change in newly diagnosed patients with PCa, and thus could be used as additional marker for this malignancy.
Publication Details
Page(s) 635-639
DOI DOI not available
Published Journal: Pakistan Journal of Biotechnology, Volume: 15, Issue: 3, Year: 2018

Request the full text from PASTIC

References
Al-MayahQ.S.,Al-SaadiM.A.,R.N.Jabbar, 2013.Trichomonas vaginalis infection as a risk factor for prostate cancer,Int. J. Curr. Microbiol. Appl. Sci 2 105 -113
Christudoss P. , Selvakumar,R. , Fleming,J.J., 2011.Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma,Indian J. Urol 27 14 -18
ClarkLC.,CombsG.F.,TurnbullB.W., 1996.Effects of selenium supplementation for cancer prevention in patients with carcinoma of skin,J. Am. Med 276 1957 -1985
Denoyer D. , Clatworthy,S.A.S. , Masaldan S, 2015.Heterogeneous copper concentrations in cancerous human prostate tissues,Prostate 75 1510 -1517
Eken A. , Kaya,E. , Unlu-Endirlik B, 2016.Evaluation of trace element levels in patients with prostate cancer, benign prostatic hyperplasia and chronic prostatitis,Gülhane Tıp. Derg 58 27 -32
Goel T. , S.N.,Sankhwar, 2006.Comparative study of zinc levels in benign and malignant lesions of the prostate,Scand. J. Urol. Nephrol 40 108 -112
Guntupalli J.N. , Padala,S. , Gummuluri,A.V., 2007.Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced Xray emission technique,Eur. J. Cancer Prev 16 108 -115
Jemal A. , Siegel,R. , Ward,E., 2007.,Cancer statistics. CA. Cancer J. Clin 57 43 -66
Ku J.H. , Seo,S.Y. , Kwak,C., 2012.The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells,Urol. Oncol 30 562 -526
Leitao R.G. , Anjos,M.J. , Canellas,C.G.L.,Brazil, 2009.Elemental concentration analysis in PCa, BPH and normal prostate tissues using SR-TXRF,Int Nuclear Atlantic Conference-INAC -
Mahmoud A.M. , Al-Alem,U. , Dabbous F, 2016.Zinc intake and risk of prostate cancer: casecontrol study and meta-analysis,PLoS One 8 -
Makhov P. , Kutikov,A. , Gonovine,K., 2011.Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: potential implication for prostate cancer therapy,Prostate 71 1413 -1413
Nayak S.B. , Bhat,V.R. , Upadhyay D, 2003.Copper and ceruloplasmin status in serum of prostate and colon cancer patients,Ind. J. Phys. Pharm 47 108 -110
ObiageliB.O.,MeluduS.C.,IlohE., 2015.Biochemical changes in some trace elements, antioxidant vitamins and their therapeutic importance in prostate cancer patients,Asian J. Med. Sci 6 95 -97
Ozmen H. , Erulas,F.A. , Karatas F, 2006.Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer,Clin. Chem. Lab. Med 44 175 -179
Sapota A. , Darago,A. , Taczalski,J.,A.Kilanowicz, 2009.Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions,Biometals 22 1041 -1049
SinghB.P.,DwivediS., 2016.Status and interrelationship of zinc, copper, iron, calcium and selenium in prostate cancer,Indian J. Clin. Biochem 3 50 -60
TheophanidesT.,J.Anastassopoulou, 2002.Copper and carcinogenesis,Crit. Rev. Oncol. Hematol 42 57 -64
YamanM.,Atici D. Bakirdere S, 2005.Comparison of trace metal concentrations in malign and benign human prostate,J. Med. Chem 48 630 -634
Yao D.H. , Johnes,A.O. , Fragmann,C.R., 1977.The content of serum zinc concentration in prostate disease,Int. J. Surg 4 225 -227
ZacharaB.A.,Szewczyk-GolecK.,Wolski Z, 2005.Selenium level in benign and cancerous prostate,Biol. Trace Elem. Res 103 199 -206
Zaichick , V., 2004.INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate,Q. J. Nucl. Med. Mol. Imaging 262 229 -234
0

Citations

0

Downloads

27

Views